SrasV1, PubMed, Corpus, bibRecord, 000809

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Identifieur interne : 000809 ( PubMed/Corpus ); précédent : 000808; suivant : 000810

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Auteurs : G. Kampf ; D. Todt ; S. Pfaender ; E. Steinmann

Source :

The Journal of hospital infection [ 1532-2939 ] ; 2020.

RBID : pubmed:32035997

English descriptors

KwdEn :
- Betacoronavirus (drug effects), Betacoronavirus (growth & development), Coronavirus Infections (transmission), Disinfectants (pharmacology), Environmental Microbiology, Humans, Microbial Viability, Pneumonia, Viral (transmission).
MESH :
- chemical , pharmacology : Disinfectants.
- drug effects : Betacoronavirus.
- growth & development : Betacoronavirus.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Environmental Microbiology, Humans, Microbial Viability.

Abstract

Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.

DOI: 10.1016/j.jhin.2020.01.022
PubMed: 32035997

Links to Exploration step

pubmed:32035997

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</title>
<author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name>
<affiliation><nlm:affiliation>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Todt, D" sort="Todt, D" uniqKey="Todt D" first="D" last="Todt">D. Todt</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pfaender, S" sort="Pfaender, S" uniqKey="Pfaender S" first="S" last="Pfaender">S. Pfaender</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steinmann, E" sort="Steinmann, E" uniqKey="Steinmann E" first="E" last="Steinmann">E. Steinmann</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32035997</idno>
<idno type="pmid">32035997</idno>
<idno type="doi">10.1016/j.jhin.2020.01.022</idno>
<idno type="wicri:Area/PubMed/Corpus">000809</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000809</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</title>
<author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name>
<affiliation><nlm:affiliation>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Todt, D" sort="Todt, D" uniqKey="Todt D" first="D" last="Todt">D. Todt</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pfaender, S" sort="Pfaender, S" uniqKey="Pfaender S" first="S" last="Pfaender">S. Pfaender</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steinmann, E" sort="Steinmann, E" uniqKey="Steinmann E" first="E" last="Steinmann">E. Steinmann</name>
<affiliation><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of hospital infection</title>
<idno type="eISSN">1532-2939</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (drug effects)</term>
<term>Betacoronavirus (growth & development)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Disinfectants (pharmacology)</term>
<term>Environmental Microbiology</term>
<term>Humans</term>
<term>Microbial Viability</term>
<term>Pneumonia, Viral (transmission)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Disinfectants</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Environmental Microbiology</term>
<term>Humans</term>
<term>Microbial Viability</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32035997</PMID>
<DateCompleted><Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2939</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>104</Volume>
<Issue>3</Issue>
<PubDate><Year>2020</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of hospital infection</Title>
<ISOAbbreviation>J. Hosp. Infect.</ISOAbbreviation>
</Journal>
<ArticleTitle>Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</ArticleTitle>
<Pagination><MedlinePgn>246-251</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0195-6701(20)30046-3</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2020.01.022</ELocationID>
<Abstract><AbstractText>Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.</AbstractText>
<CopyrightInformation>Copyright © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kampf</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Todt</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pfaender</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steinmann</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>02</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Hosp Infect</MedlineTA>
<NlmUniqueID>8007166</NlmUniqueID>
<ISSNLinking>0195-6701</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004202">Disinfectants</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004202" MajorTopicYN="N">Disinfectants</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004783" MajorTopicYN="N">Environmental Microbiology</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050296" MajorTopicYN="Y">Microbial Viability</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biocidal agents</Keyword>
<Keyword MajorTopicYN="N">Chemical inactivation</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Disinfection</Keyword>
<Keyword MajorTopicYN="N">Inanimate surfaces</Keyword>
<Keyword MajorTopicYN="N">Persistence</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>01</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>01</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32035997</ArticleId>
<ArticleId IdType="pii">S0195-6701(20)30046-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.jhin.2020.01.022</ArticleId>
<ArticleId IdType="pmc">PMC7132493</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet. 2020 Feb 15;395(10223):514-523</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986261</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Epidemiol Infect. 1989 Jun;102(3):493-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2737256</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2017 Mar 15;215(6):902-906</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28453839</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Resist Infect Control. 2016 May 23;5:21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27222710</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 1991 Oct;29(10):2115-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1658033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2005 Oct;61(2):107-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15923059</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 1998 Apr;38(4):283-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9602977</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Dis Ther. 2018 Jun;7(2):249-259</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29633177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2014 Apr;86(4):255-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24656442</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2004 Sep 1;39(5):652-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15356778</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2000 Sep;46(1):55-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11023724</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2005 Oct 1;41(7):e67-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16142653</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1985 Dec;66 ( Pt 12):2743-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2999318</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2011 Jun;39(5):401-407</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21256627</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2015 Nov 10;6(6):e01697-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26556276</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Healthcare (Basel). 2018 Oct 07;6(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30301272</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Viruses. 2012 Nov 12;4(11):3044-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23202515</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Zoonoses Public Health. 2007;54(9-10):383-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18035977</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 1982 Jul;146(1):47-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6282993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med Microbiol Immunol. 2005 Jan;194(1-2):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15118911</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Virol. 2011;2011:734690</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22312351</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vet J. 2008 Jul;177(1):71-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17513145</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2019 Apr;47(4):431-434</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30502108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Scand J Infect Dis. 2010 Jul;42(6-7):510-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20148749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Appl Environ Microbiol. 2010 May;76(9):2712-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20228108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2016 Aug;14(8):523-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27344959</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Pulm Med. 2019 Oct 30;19(1):190</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31666061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Dis Ther. 2015 Dec;4(4):491-501</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26416214</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2013 Sep 19;18(38):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24084338</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2015 Feb;43(2):112-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25637115</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Jikken Dobutsu. 1988 Jul;37(3):341-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3416941</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2009 Oct;37(8):649-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19692148</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biomed Environ Sci. 2003 Sep;16(3):246-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14631830</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2006 Jun;34(5):251-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16765201</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2016 Mar;92(3):235-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26597631</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2005 Dec;33(10):580-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16330306</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Dermatology. 2006;212 Suppl 1:119-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16490989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000809 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000809 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32035997
   |texte=   Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:32035997" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki